Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy

<table class="fixed-width table-group" id="tab3"><tr><td><table class="table"><colgroup><col style="width:15.77em"/><col style="width:11.31em"/><col style="width:11.31em"/><col style="width:11.31em"/><col style="width:11.31em"/></colgroup><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Time (Week)</td><td class="align_center">Clinical control (n)</td><td class="align_center">Obvious treatment effect (n)</td><td class="align_center">mild treatment effect (n)</td><td class="align_center">Clinical efficiency (%)</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">3</td><td class="align_center">2</td><td class="align_center">13</td><td class="align_center">29</td><td class="align_center">36.11</td></tr><tr><td class="align_left">8/9</td><td class="align_center">4</td><td class="align_center">23</td><td class="align_center">45</td><td class="align_center">50.93</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The improvement of TCM syndrome.</div>

Evidence-Based Complementary and Alternative Medicine

tab3

Table 3

Table 3: Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy 